Select Language

VP2

VP2 Product List

Product Category
Protein (5)
Product Status
Launched (5)
Species
Adeno-associated virus 2 (1)Adeno-associated virus 8 (1)Adeno-associated virus 9 (1)Adeno-associated virus 5 (1)Adeno-associated virus 6 (1)
Tag
His Tag (5)
Conjugate
Unconjugated (5)

Cat. No.	Species	Host	Product Description
HOT VP2-A5144	Adeno-associated virus 5	E. coli	AAV5 VP2, Recombinant Protein
HOT VP2-A5145	Adeno-associated virus 9	E. coli	AAV9 VP2, Recombinant Protein
HOT VP2-A5146	Adeno-associated virus 8	E. coli	AAV8 VP2, Recombinant Protein
VP2-A5143	Adeno-associated virus 2	E. coli	AAV2 VP2, Recombinant Protein
VP2-A5147	Adeno-associated virus 6	E. coli	AAV6 VP2, Recombinant Protein

Total: 5

VP2 Background

Adeno-associated virus is a single-stranded DNA virus and the current scientific consensus is that it does not cause any human disease. It consists of a protein capsid (CAPside) and a 4.7 KB length single stranded DNA genome. The protein capsid consists of three subunits, VP1, VP2, and VP3.

Clinical Drug Information

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
NKG2D-ACE2 CAR-NK cell therapy (Sidemu Biotechnology Technology)		Phase 2 Clinical		Coronavirus Disease 2019 (COVID-19)	Details
CTB-ACE2	CTB-ACE2	Phase 2 Clinical	University Of Pennsylvania	Coronavirus Disease 2019 (COVID-19)	Details
HH-120	HH-120	Phase 2 Clinical	Huahui Health Ltd	Coronavirus Disease 2019 (COVID-19)	Details
B38-CAP		Phase 1 Clinical	Akita University	Coronavirus Disease 2019 (COVID-19)	Details
68Ga-labeled ACE2 Targeting Probe(Peking Union Medical College Hospital)	68Ga-A3	Phase 1 Clinical	Peking Union Medical College Hospital	Small Cell Lung Carcinoma; Lung Neoplasms	Details
AOD01	AOD01; AOD-01	Phase 1 Clinical	A*Star	Coronavirus Disease 2019 (COVID-19)	Details
SBK-001	SBK-001	Phase 1 Clinical	Chengdu Shibeikang Biomedical Technology Co Ltd	Acute Lung Injury	Details